Piecemeal degranulation in human eosinophils: A distinct secretion mechanism underlying inflammatory responses

Histology and Histopathology

Volumn 25, Issue 10, 2010, Pages 1341-1354

  Melo, Rossana C N ^a,b   Weller, Peter F ^b  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Electron microscopy; Electron tomography; Human eosinophils; Inflammation; Piecemeal degranulation; Vesicle mediated secretion

Indexed keywords

AUTACOID; CYTOKINE;

DEGRANULATION; EOSINOPHIL; HUMAN; IMMUNOLOGY; INFLAMMATION; METABOLISM; PATHOLOGY; REVIEW; SECRETION; TRANSPORT VESICLE; ULTRASTRUCTURE;

CELL DEGRANULATION; CYTOKINES; EOSINOPHILS; HUMANS; INFLAMMATION; INFLAMMATION MEDIATORS; TRANSPORT VESICLES;

EID: 79451470428     PISSN: 02133911     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (90)

1. Ackerman S.J. and Bochner B.S. (2007). Mechanisms of eosinophilia in the pathogenesis of hypereosinophilic disorders. Immunol. Allergy Clin. North Am. 27, 357-375.
2. Adamko D.J., Odemuyiwa S.O., Vethanayagam D. and Moqbel R. (2005). The rise of the phoenix: The expanding role of the eosinophil in health and disease. Allergy 60, 13-22.
3. Ahlstrom-Emanuelsson C.A., Greiff L., Andersson M., Persson C.G. and Erjefalt J.S. (2004). Eosinophil degranulation status in allergic rhinitis: Observations before and during seasonal allergen exposure. Eur. Respir. J. 24, 750-757.
4. Armengot M., Garin L. and Carda C. (2009). Eosinophil degranulation patterns in nasal polyposis: An ultrastructural study. Am. J. Rhinol. Allergy 23, 466-470.
5. Bandeira-Melo C., Sugiyama K., Woods L.J. and Weller P.F. (2001). Cutting edge: Eotaxin elicits rapid vesicular transport-mediated release of preformed IL-4 from human eosinophils. J. Immunol. 166, 4813-4817.
6. Bandeira-Melo C., Perez S.A.C., Melo R.C.N., Ghiran I. and Weller P.F. (2003). Elicell assay for the detection of released cytokines from eosinophils. J. Immunol. Methods 276, 227-237.
7. Barois N., de Saint-Vis B., Lebecque S., Geuze H.J. and Kleijmeer M.J. (2002). MHC class II compartments in human dendritic cells undergo profound structural changes upon activation. Traffic 3, 894-905.
8. Behzad A.R., Walker D.C., Abraham T., McDonough J., Mahmudi-Azer S., Chu F., Shaheen F., Hogg J.C. and Pare P.D. (2009). Localization of DNA and RNA in eosinophil secretory granules. Int. Arch. Allergy Immunol. 152, 12-27.
9. Beil W.J., Weller P.F., Tzizik D.M., Galli S.J. and Dvorak A.M. (1993). Ultrastructural immunogold localization of tumor necrosis factoralpha to the matrix compartment of eosinophil secondary granules in patients with idiopathic hypereosinophilic syndrome. J. Histochem. Cytochem. 41, 1611-1615.
10. Broide D.H., Paine M.M. and Firestein G.S. (1992). Eosinophils express interleukin 5 and granulocyte macrophage-colony-stimulating factor mRNA at sites of allergic inflammation in asthmatics. J. Clin. Invest. 90, 1414-1424.
11. Caruso R.A., Ieni A., Fedele F., Zuccala V., Riccardo M., Parisi E. and Parisi A. (2005). Degranulation patterns of eosinophils in advanced gastric carcinoma: An electron microscopic study. Ultrastruct. Pathol. 29, 29-36.
12. Chen X., Winters C.A. and Reese T.S. (2008). Life inside a thin section: Tomography. J. Neurosci. 28, 9321-9327.
13. Cheng J.F., Ott N.L., Peterson E.A., George T.J., Hukee M.J., Gleich G.J. and Leiferman K.M. (1997). Dermal eosinophils in atopic dermatitis undergo cytolytic degeneration. J. Allergy Clin. Immunol. 99, 683-692.
14. Crivellato E., Nico B., Mallardi F., Beltrami C.A. and Ribatti D. (2003). Piecemeal degranulation as a general secretory mechanism? Anat. Rec. 274A, 778-784.
15. Desreumaux P., Delaporte E., Colombel J.F., Capron M., Cortot A. and Janin A. (1998). Similar IL-5, IL-3, and GM-CSF syntheses by eosinophils in the jejunal mucosa of patients with celiac disease and dermatitis herpetiformis. Clin. Immunol. Immunopathol. 88, 14-21.
16. Dubucquoi S., Desreumaux P., Janin A., Klein O., Goldman M., Tavernier J., Capron A. and Capron M. (1994). Interleukin 5 synthesis by eosinophils: Association with granules and immunoglobulin-dependent secretion. J. Exp. Med. 179, 703-708.
17. Dvorak A.M. (1980). Ultrastructural evidence for release of major basic protein-containing crystalline cores of eosinophil granules in vivo: Cytotoxic potential in Crohn's disease. J. Immunol. 125, 460-462.
18. Dvorak A.M. (1992a). Human mast cells. Ultrastructural observations of in situ, ex vivo, and in vitro studies, sources, and systems. In: The mast cell in health and disease. Kaliner M.A.M. (ed). pp. 1-90.
19. Dvorak A.M. (1992b). Basophils and mast cells: Piecemeal degranulation in situ and ex vivo: A possible mechanism for cytokine-induced function in disease. In: Granulocyte responses to cytokines-basic and clinical research. Coffey R.G. (ed). New York. Marcel Dekker. pp. 169-271.
20. Dvorak A.M. (1998). A role for vesicles in human basophil secretion. Cell Tissue Res. 293, 1-22.
21. Dvorak A.M. (2005a). Ultrastructure of mast cells and basophils. Chemical Immunology Series. S. Karger. Basel. pp. 1-250.
22. Dvorak A.M. (2005b). Piecemeal degranulation of basophils and mast cells is effected by vesicular transport of stored secretory granule contents. Chem. Immunol. Allergy 85, 135-184.
23. Dvorak A.M. and Weller P.F. (2000). Ultrastructural analysis of human eosinophils. In: Human eosinophils: Biological and chemical aspects. Marone G. (ed). Basel. Karger. pp. 1-28.
24. Dvorak A.M., Monahan R.A., Osage J.E. and Dickersin G.R. (1980). Crohn's disease: Transmission electron microscopic studies. II. Immunologic inflammatory response. Alterations of mast cells, basophils, eosinophils, and the microvasculature. Hum. Pathol. 11, 606-619.
25. Dvorak A.M., Weller P.F., Monahan-Earley R.A., Letourneau L. and Ackerman S.J. (1990). Ultrastructural localization of charcot-leyden crystal protein (lysophospholipase) and peroxidase in macrophages, eosinophils, and extracellular matrix of the skin in the hypereosinophilic syndrome. Lab. Invest. 62, 590-607.
26. Dvorak A.M., Furitsu T., Letourneau L., Ishizaka T. and Ackerman S.J. (1991). Mature eosinophils stimulated to develop in human cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. I. Piecemeal degranulation of specific granules and distribution of charcot-leyden crystal protein. Am. J. Pathol. 138, 69-82.
27. Dvorak A.M., Ackerman S.J., Furitsu T., Estrella P., Letourneau L. and Ishizaka T. (1992). Mature eosinophils stimulated to develop in human-cord blood mononuclear cell cultures supplemented with recombinant human interleukin-5. II. Vesicular transport of specific granule matrix peroxidase, a mechanism for effecting piecemeal degranulation. Am. J. Pathol. 140, 795-807.
28. Dvorak A.M., Estrella P. and Ishizaka T. (1994). Vesicular transport of peroxidase in human eosinophilic myelocytes. Clin. Exp. Allergy 24, 10-18.
29. Egesten A., Alumets J., von Mecklenburg C., Palmegren M. and Olsson I. (1986). Localization of eosinophil cationic protein, major basic protein, and eosinophil peroxidase in human eosinophils by immunoelectron microscopic technique. J. Histochem. Cytochem. 34, 1399-1403.
30. Egesten A., Calafat J., Knol E.F., Janssen H. and Walz T.M. (1996). Subcellular localization of transforming growth factor-alpha in human eosinophil granulocytes. Blood 87, 3910-3918.
31. Erjefalt J.S. and Persson C.G. (2000). New aspects of degranulation and fates of airway mucosal eosinophils. Am. J. Respir. Crit. Care Med. 161, 2074-2085.
32. Erjefalt J.S., Greiff L., Andersson M., Adelroth E., Jeffery P.K. and Persson C.G. (2001). Degranulation patterns of eosinophil granulocytes as determinants of eosinophil driven disease. Thorax 56, 341-344.
33. Foley S.C., Prefontaine D. and Hamid Q. (2007). Images in allergy and immunology: Role of eosinophils in airway remodeling. J. Allergy Clin. Immunol.119, 1563-1566.
34. Fujisawa T., Fukuda S., Atsuta J., Ichimi R., Kamiya H. and Sakurai M. (1994). Interferon-gamma induces interleukin-3 release from peripheral blood eosinophils. Int. Arch. Allergy Immunol. 104 (Suppl 1), 41-43.
35. Gleich G.J. (2000). Mechanisms of eosinophil-associated inflammation. J. Allergy Clin. Immunol. 105, 651-663.
36. Gleich G.J., Loegering D.A. and Maldonado J.E. (1973). Identification of a major basic protein in guinea pig eosinophil granules. J. Exp. Med. 137, 1459-1471.
37. Hartman M., Piliponsky A.M., Temkin V. and Levi-Schaffer F. (2001). Human peripheral blood eosinophils express stem cell factor. Blood 97, 1086-1091.
38. Heijnen H.F., Debili N., Vainchencker W., Breton-Gorius J., Geuze H.J. and Sixma J.J. (1998). Multivesicular bodies are an intermediate stage in the formation of platelet alpha-granules. Blood 91, 2313-2325.
39. Horiuchi T. and Weller P.F. (1997). Expression of vascular endothelial growth factor by human eosinophils: Upregulation by granulocyte macrophage colony-stimulating factor and interleukin-5. Am. J. Respir. Cell. Mol. Biol. 17, 70-77.
40. Jacobsen E.A., Taranova A.G., Lee N.A. and Lee J.J. (2007). Eosinophils: Singularly destructive effector cells or purveyors of immunoregulation? J. Allergy Clin. Immunol. 119, 1313-1320.
41. Karawajczyk M., Seveus L., Garcia R., Bjornsson E., Peterson C.G., Roomans G.M. and Venge P. (2000). Piecemeal degranulation of peripheral blood eosinophils: A study of allergic subjects during and out of the pollen season. Am. J. Respir. Cell. Mol. Biol. 23, 521-529.
42. Kita H., Adolphson C. and Gleich G. (1998). Biology of eosinophils. In: Allergy: Principles and practice. 5 ed. Adkinson N.F., Ellis E.F., Middleton E., Reed C.E. and Yunginger J.W. (eds). Mosby. St. Louis. pp. 242-260.
43. Lacy P. and Moqbel R. (2000). Eosinophil cytokines. Chem. Immunol. 76, 134-155.
44. Lacy P., Levi-Schaffer F., Mahmudi-Azer S., Bablitz B., Hagen S.C., Velazquez J., Kay A.B. and Moqbel R. (1998). Intracellular localization of interleukin-6 in eosinophils from atopic asthmatics and effects of interferon gamma. Blood 91, 2508-2516.
45. Lacy P., Mahmudi-Azer S., Bablitz B., Hagen S.C., Velazquez J.R., Man S.F. and Moqbel R. (1999). Rapid mobilization of intracellularly stored RANTES in response to interferon-gamma in human eosinophils. Blood 94, 23-32.
46. Lacy P., Logan M.R., Bablitz B. and Moqbel R. (2001). Fusion protein vesicle-associated membrane protein 2 is implicated in IFN-gammainduced piecemeal degranulation in human eosinophils from atopic individuals. J. Allergy Clin. Immunol. 107, 671-678.
47. Levi-Schaffer F., Lacy P., Severs N.J., Newman T.M., North J., Gomperts B., Kay A.B. and Moqbel R. (1995). Association of granulocyte-macrophage colony-stimulating factor with the crystalloid granules of human eosinophils. Blood 85, 2579-2586.
48. Levi-Schaffer F., Barkans J., Newman T.M., Ying S., Wakelin M., Hohenstein R., Barak V., Lacy P., Kay A.B. and Moqbel R. (1996). Identification of interleukin-2 in human peripheral blood eosinophils. Immunology 87, 155-161.
49. Lewis D.M., Lewis J.C., Loegering D.A. and Gleich G.J. (1978). Localization of the guinea pig eosinophil major basic protein to the core of the granule. J. Cell Biol. 77, 702-713.
50. Lim K.G., Wan H.C., Bozza P.T., Resnick M.B., Wong D.T., Cruikshank W.W., Kornfeld H., Center D.M. and Weller P.F. (1996). Human eosinophils elaborate the lymphocyte chemoattractants. IL-16 (lymphocyte chemoattractant factor) and RANTES. J. Immunol. 156, 2566-2570.
51. Logan M.R., Odemuyiwa S.O. and Moqbel R. (2003). Understanding exocytosis in immune and inflammatory cells: The molecular basis of mediator secretion. J. Allergy Clin. Immunol. 111, 923-932; quiz 933.
52. Logan M.R., Lacy P., Bablitz B. and Moqbel R. (2002). Expression of eosinophil target snares as potential cognate receptors for vesicleassociated membrane protein-2 in exocytosis. J. Allergy Clin. Immunol. 109, 299-306.
53. Luini A., Ragnini-Wilson A., Polishchuck R.S. and De Matteis M.A. (2005). Large pleiomorphic traffic intermediates in the secretory pathway. Curr. Opin. Cell Biol. 17, 353-361.
54. Mahmudi-Azer S., Downey G.P. and Moqbel R. (2002). Translocation of the tetraspanin CD63 in association with human eosinophil mediator release. Blood 99, 4039-4047.
55. Melo R.C.N., Weller P.F. and Dvorak A.M. (2005a). Activated human eosinophils. Int. Arch. Allergy Immunol. 138, 347-349.
56. Melo R.C.N., Perez S.A.C., Spencer L.A., Dvorak A.M. and Weller P.F. (2005b). Intragranular vesiculotubular compartments are involved in piecemeal degranulation by activated human eosinophils. Traffic 6, 866-879.
57. Melo R.C.N., Spencer L.A., Perez S.A.C., Ghiran I., Dvorak A.M. and Weller P.F. (2005c). Human eosinophils secrete preformed, granulestored interleukin-4 (IL-4) through distinct vesicular compartments. Traffic 6, 1047-1057.
58. Melo R.C.N., Dvorak A.M. and Weller P.F. (2008a). Electron tomography and immunonanogold electron microscopy for investigating intracellular trafficking and secretion in human eosinophils. J. Cell. Mol. Med. 12, 1416-1419.
59. Melo R.C.N., Spencer L.A., Dvorak A.M. and Weller P.F. (2008b). Mechanisms of eosinophil secretion: Large vesiculotubular carriers mediate transport and release of granule-derived cytokines and other proteins. J. Leukoc. Biol. 83, 229-236.
60. Melo R.C.N., Spencer L.A., Perez S.A., Neves J.S., Bafford S.P., Morgan E.S., Dvorak A.M. and Weller P.F. (2009). Vesicle-mediated secretion of human eosinophil granule-derived major basic protein. Lab. Invest. 89, 769-781.
61. Moller G.M., de Jong T.A., Overbeek S.E., van der Kwast T.H., Postma D.S. and Hoogsteden H.C. (1996a). Ultrastructural immunogold localization of interleukin 5 to the crystalloid core compartment of eosinophil secondary granules in patients with atopic asthma. J. Histochem. Cytochem. 44, 67-69.
62. Moller G.M., de Jong T.A., van der Kwast T.H., Overbeek S.E., Wierenga-Wolf A.F., Thepen T. and Hoogsteden H.C. (1996b). Immunolocalization of interleukin-4 in eosinophils in the bronchial mucosa of atopic asthmatics. Am. J. Respir. Cell. Mol. Biol. 14, 439-443.
63. Moqbel R. and Coughlin J.J. (2006). Differential secretion of cytokines. (2006) Sci. STKE 338, pe26.
64. Moqbel R., Ying S., Barkans J., Newman T.M., Kimmitt P., Wakelin M., Taborda-Barata L., Meng Q., Corrigan C.J. and Durham S.R. (1995). Identification of messenger RNA for IL-4 in human eosinophils with granule localization and release of the translated product. J. Immunol. 155, 4939-4947.
65. Munitz A. and Levi-Schaffer F. (2004). Eosinophils: 'new' roles for 'old' cells. Allergy 59, 268-275.
66. Nakajima T., Yamada H., Iikura M., Miyamasu M., Izumi S., Shida H., Ohta K., Imai T., Yoshie O., Mochizuki M., Schroder J.M., Morita Y., Yamamoto K. and Hirai K. (1998). Intracellular localization and release of eotaxin from normal eosinophils. FEBS Lett. 434, 226-230.
67. Nebenfuhr A., Ritzenthaler C. and Robinson D.G. (2002). Brefeldin A: Deciphering an enigmatic inhibitor of secretion. Plant Physiol. 130, 1102-1108.
68. Persson-Dajotoy T., Andersson P., Bjartell A., Calafat J. and Egesten A. (2003). Expression and production of the CXC chemokine growthrelated oncogene-alpha by human eosinophils. J. Immunol. 170, 5309-5316.
69. Persson T., Monsef N., Andersson P., Bjartell A., Malm J., Calafat J. and Egesten A. (2003). Expression of the neutrophil-activating CXC chemokine ENA-78/CXCL5 by human eosinophils. Clin. Exp. Allergy 33, 531-537.
70. Peters M.S., Rodriguez M. and Gleich G.J. (1986). Localization of human eosinophil granule major basic protein, eosinophil cationic protein, and eosinophil-derived neurotoxin by immunoelectron microscopy. Lab. Invest. 54, 656-662.
71. Qadri F., Bhuiyan T.R., Dutta K.K., Raqib R., Alam M.S., Alam N.H., Svennerholm A.M. and Mathan M.M. (2004). Acute dehydrating disease caused by vibrio cholerae serogroups 01 and 0139 induce increases in innate cells and inflammatory mediators at the mucosal surface of the gut. Gut 53, 62-69.
72. Raqib R., Moly P.K., Sarker P., Qadri F., Alam N.H., Mathan M. and Andersson J. (2003). Persistence of mucosal mast cells and eosinophils in shigella-infected children. Infect. Immun. 71, 2684-2692.
73. Rosenberg H.F., Phipps S. and Foster P.S. (2007). Eosinophil trafficking in allergy and asthma. J Allergy Clin. Immunol. 119, 1303-1310; quiz 1311-1302.
74. Rothenberg M.E. and Hogan S.P. (2006). The eosinophil. Annu. Rev. Immunol. 24, 147-174.
75. Simpson J.C., Nilsson T. and Pepperkok R. (2006). Biogenesis of tubular ER-to-golgi transport intermediates. Mol. Biol. Cell. 17, 723-737.
76. Specht S., Saeftel M., Arndt M., Endl E., Dubben B., Lee N.A., Lee J.J. and Hoerauf A. (2006). Lack of eosinophil peroxidase or major basic protein impairs defense against murine filarial infection. Infect. Immun. 74, 5236-5243.
77. Spencer L.A., Melo R.C.N., Perez S.A., Bafford S.P., Dvorak A.M. and Weller P.F. (2006). Cytokine receptor-mediated trafficking of preformed IL-4 in eosinophils identifies an innate immune mechanism of cytokine secretion. Proc. Natl. Acad. Sci. USA 103, 3333-3338.
78. Spencer L.A., Szela C.T., Perez S.A., Kirchhoffer C.L., Neves J.S., Radke A.L. and Weller P.F. (2009). Human eosinophils constitutively express multiple Th1, Th2, and immunoregulatory cytokines that are secreted rapidly and differentially. J. Leukoc. Biol. 85, 117-123.
79. Staehelin L.A. and Kang B.H. (2008). Nanoscale architecture of endoplasmic reticulum export sites and of Golgi membranes as determined by electron tomography. Plant Physiol. 147, 1454-1468.
80. Tai P.C., Ackerman S.J., Spry C.J., Dunnette S., Olsen E.G. and Gleich G.J. (1987). Deposits of eosinophil granule proteins in cardiac tissues of patients with eosinophilic endomyocardial disease. Lancet 1, 643-647.
81. Torpier G., Colombel J.F., Mathieu-Chandelier C., Capron M., Dessaint J.P., Cortot A., Paris J.C. and Capron A. (1988). Eosinophilic gastroenteritis: Ultrastructural evidence for a selective release of eosinophil major basic protein. Clin. Exp. Immunol. 74, 404-408.
82. Toyoda M., Nakamura M., Makino T. and Morohashi M. (2003). Localization and content of nerve growth factor in peripheral blood eosinophils of atopic dermatitis patients. Clin. Exp. Allergy 33, 950-955.
83. Trivedi S.G. and Lloyd C.M. (2007). Eosinophils in the pathogenesis of allergic airways disease. Cell. Mol. Life Sci. 64, 1269-1289.
84. Trucco A., Polishchuk R.S., Martella O., Di Pentima A., Fusella A., Di Giandomenico D., San Pietro E., Beznoussenko G.V., Polishchuk E.V., Baldassarre M., Buccione R., Geerts W.J., Koster A.J., Burger K.N., Mironov A.A. and Luini A. (2004). Secretory traffic triggers the formation of tubular continuities across Golgi sub-compartments. Nat. Cell Biol. 6, 1071-1081.
85. Watson P. and Stephens D.J. (2005). ER-to-Golgi transport: Form and formation of vesicular and tubular carriers. Biochim. Biophys. Acta 1744, 304-315.
86. Weller P.F., Neves J.S., Perez S.A., Melo R.C.N., Spencer L.A. and Dvorak A.M. (2009). Mechanisms of human eosinophil secretion. Cytokine 48, 40.
87. Wickner W. and Schekman R. (2008). Membrane fusion. Nat. Struct. Mol. Biol. 15, 658-664.
88. Woerly G., Lacy P., Younes A.B., Roger N., Loiseau S., Moqbel R. and Capron M. (2002). Human eosinophils express and release IL-13 following CD28-dependent activation. J. Leukoc. Biol. 72, 769-779.
89. Wong D.T., Weller P.F., Galli S.J., Elovic A., Rand T.H., Gallagher G.T., Chiang T., Chou M.Y., Matossian K. and McBride J. (1990). Human eosinophils express transforming growth factor alpha. J. Exp. Med. 172, 673-681.
90. Ying S., Meng Q., Taborda-Barata L., Corrigan C.J., Barkans J., Assoufi B., Moqbel R., Durham S.R. and Kay A.B. (1996). Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein. Eur. J. Immunol. 26, 70-76.